A roadmap to ALS prevention: strategies and priorities.
作者信息
Benatar Michael, Goutman Stephen A, Staats Kim A, Feldman Eva L, Weisskopf Marc, Talbott Evelyn, Dave Kuldip D, Thakur Neil M, Al-Chalabi Ammar
机构信息
Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA
Neurology, University of Michigan, Ann Arbor, Michigan, USA.
出版信息
J Neurol Neurosurg Psychiatry. 2023 May;94(5):399-402. doi: 10.1136/jnnp-2022-330473. Epub 2023 Jan 23.
Abstract
摘要
相似文献
1
A roadmap to ALS prevention: strategies and priorities.
J Neurol Neurosurg Psychiatry. 2023 May;94(5):399-402. doi: 10.1136/jnnp-2022-330473. Epub 2023 Jan 23.
2
CDC Grand Rounds: National Amyotrophic Lateral Sclerosis (ALS) Registry Impact, Challenges, and Future Directions.
MMWR Morb Mortal Wkly Rep. 2017 Dec 22;66(50):1379-1382. doi: 10.15585/mmwr.mm6650a3.
3
Amyotrophic lateral sclerosis caused by SOD1 variants: from genetic discovery to disease prevention.
Lancet Neurol. 2025 Jan;24(1):77-86. doi: 10.1016/S1474-4422(24)00479-4.
4
Dietary fiber and amyotrophic lateral sclerosis: results from 5 large cohort studies.
Am J Epidemiol. 2014 Jun 15;179(12):1442-9. doi: 10.1093/aje/kwu089. Epub 2014 May 9.
5
Does treating schizophrenia reduce the chances of developing amyotrophic lateral sclerosis?
Med Hypotheses. 2007;69(5):1021-8. doi: 10.1016/j.mehy.2007.02.041. Epub 2007 May 1.
6
Identifying potential targets for prevention and treatment of amyotrophic lateral sclerosis based on a screen of medicare prescription drugs.
Amyotroph Lateral Scler Frontotemporal Degener. 2020 May;21(3-4):235-245. doi: 10.1080/21678421.2019.1682613. Epub 2019 Nov 4.
7
Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit.
Neurol Ther. 2023 Dec;12(6):1821-1843. doi: 10.1007/s40120-023-00548-8. Epub 2023 Oct 17.
8
N-acetyl-L-tryptophan delays disease onset and extends survival in an amyotrophic lateral sclerosis transgenic mouse model.
Neurobiol Dis. 2015 Aug;80:93-103. doi: 10.1016/j.nbd.2015.05.002. Epub 2015 May 16.
9
Dietary ω-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis.
JAMA Neurol. 2014 Sep;71(9):1102-10. doi: 10.1001/jamaneurol.2014.1214.
10
Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis.
Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14(4):246-51. doi: 10.3109/21678421.2012.745570. Epub 2013 Jan 4.
引用本文的文献
1
Improving prediction models of amyotrophic lateral sclerosis (ALS) using polygenic, pre-existing conditions, and survey-based risk scores in the UK Biobank.
J Neurol. 2024 Oct;271(10):6923-6934. doi: 10.1007/s00415-024-12644-2. Epub 2024 Sep 9.
2
Nanoplastics and Neurodegeneration in ALS.
Brain Sci. 2024 May 7;14(5):471. doi: 10.3390/brainsci14050471.
3
Environmental risk scores of persistent organic pollutants associate with higher ALS risk and shorter survival in a new Michigan case/control cohort.
J Neurol Neurosurg Psychiatry. 2024 Feb 14;95(3):241-248. doi: 10.1136/jnnp-2023-332121.
4
The amyotrophic lateral sclerosis exposome: recent advances and future directions.
Nat Rev Neurol. 2023 Oct;19(10):617-634. doi: 10.1038/s41582-023-00867-2. Epub 2023 Sep 14.
5
Presymptomatic amyotrophic lateral sclerosis: from characterization to prevention.
Curr Opin Neurol. 2023 Aug 1;36(4):360-364. doi: 10.1097/WCO.0000000000001168. Epub 2023 May 31.
6
Reply: A new diagnostic entity must enable earlier treatment in gene carriers.
Brain. 2023 Oct 3;146(10):e80-e82. doi: 10.1093/brain/awad165.
本文引用的文献
1
Trial of Antisense Oligonucleotide Tofersen for ALS.
N Engl J Med. 2022 Sep 22;387(12):1099-1110. doi: 10.1056/NEJMoa2204705.
2
Medication use and risk of amyotrophic lateral sclerosis-a systematic review.
BMC Med. 2022 Aug 5;20(1):251. doi: 10.1186/s12916-022-02442-w.
3
Mild motor impairment as prodromal state in amyotrophic lateral sclerosis: a new diagnostic entity.
Brain. 2022 Oct 21;145(10):3500-3508. doi: 10.1093/brain/awac185.
4
Associations of self-reported occupational exposures and settings to ALS: a case-control study.
Int Arch Occup Environ Health. 2022 Sep;95(7):1567-1586. doi: 10.1007/s00420-022-01874-4. Epub 2022 May 20.
5
Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy.
Front Immunol. 2022 Jan 20;12:816515. doi: 10.3389/fimmu.2021.816515. eCollection 2021.
6
Incidence of amyotrophic lateral sclerosis in the United States, 2014-2016.
Amyotroph Lateral Scler Frontotemporal Degener. 2022 Aug;23(5-6):378-382. doi: 10.1080/21678421.2021.2023190. Epub 2022 Jan 13.
7
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.
Nat Genet. 2021 Dec;53(12):1636-1648. doi: 10.1038/s41588-021-00973-1. Epub 2021 Dec 6.
8
Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.
Brain. 2022 Mar 29;145(1):27-44. doi: 10.1093/brain/awab404.
9
Parkinsonism and motor neuron disorders: Lessons from Western Pacific ALS/PDC.
J Neurol Sci. 2022 Feb 15;433:120021. doi: 10.1016/j.jns.2021.120021. Epub 2021 Oct 2.
10
Pesticides applied to crops and amyotrophic lateral sclerosis risk in the U.S.
Neurotoxicology. 2021 Dec;87:128-135. doi: 10.1016/j.neuro.2021.09.004. Epub 2021 Sep 22.
Zotero 插件